How to Buy Disc Medicine Stock
Disc Medicine Inc
Disc Medicine, Inc. , a clinical-stage biotechnology company, engages in discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases.
Disc Medicine stock last closed at $61.36, down 3.14% from the previous day, and has increased 12.9% in one year. It has overperformed other stocks in the Biotechnology industry by 0.43 percentage points. Disc Medicine stock is currently +99.09% from its 52-week low of $30.82, and -38.33% from its 52-week high of $99.50.
At the moment, there are 37.75M IRON shares outstanding. The market cap of IRON is $2.32B. In the past 24 hours, 920,000 IRON shares were traded.
How to Buy Disc Medicine Stock
Wondering how to invest in Disc Medicine stock? Here's how.
- Figure out where to buy Disc Medicine stock: You need to pick a stock brokerage, but don't worry - we've analyzed dozens of online brokerages and apps to help you choose where to buy Disc Medicine stock.
- Open a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
- Deposit money your brokerage account: Choose your method of payment and add your details.
- Research Disc Medicine stock: The Disc Medicine ticker symbol is IRON. Is Disc Medicine stock a good investment? Should you buy shares of IRON? How do IRON's underlying business fundamentals look? Do top analysts think Disc Medicine is a good buy? Why has IRON's stock price moved recently? (Hint: Our stock analysis website can help you evaluate if IRON is a good stock to buy).
- Make your IRON buy order: Decide if you will purchase IRON shares at the current market price or use a limit order to purchase IRON shares at a specific price.
- Watch your IRON position: Create a watchlist to important updates regarding your new investment in Disc Medicine shares.
Step 1: Figure out where to buy Disc Medicine stock
You need a brokerage account to access the NASDAQ market and buy IRON stock.
Our favorite brokerage: eToro
Based on our analysis, eToro is the best brokerage. Here's why:
- Invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
- Access to world markets: From Technology to Utilities, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top stock exchanges.
- Social investing: eToro offers a community of more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your purchase of stock by creating an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Open a brokerage account
Now that you've picked your brokerage, the next step is to fill out some personal info so you can buy IRON stock today.
How to Open a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal info to start your new brokerage account.
- Submit your application by clicking the "Create Account" button. Get started with eToro today
Step 3: Deposit money your brokerage account
Now that you've created your account on stock apps to use, you need to deposit funds:
Watch the tutorial below if you need help depositing funds into your new investment account.
Step 4: Research Disc Medicine stock
After you have figured out the best place to buy Disc Medicine stock, it's very important to evaluate their stock before you buy, so you actually wrap your head around the risk as well as the upside.
Overview of key IRON info
Fundamentals of Disc Medicine
WallStreetZen was created to help everyday investors do more accurate fundamental analysis in less time.
You can see all of the due diligence checks on IRON's stock page.
Is IRON stock properly valued?
Investors use a variety of different financial metrics, analyses, models, and charts to gauge IRON's intrinsic value.
Using relative valuations metrics:
- IRON may be undervalued based on its P/B ratio of 4.04x, relative to Biotechnology industry P/B ratio of 5.17x
You can do more valuation analysis on IRON's stock here.
A look at IRON Cashflows and Balance Sheet
Pros:
- There are more short-term assets than long-term liabilities on the IRON balance sheet.
- Total IRON debt is lower than 5 years ago, relative to shareholder equity.
- IRON has a low debt to equity ratio of 0.1.
- IRON has cash burn of 166028000. It has enough cash and short-term investments to cover this for at least one year.
- There are more short-term assets than short-term liabilities on the IRON balance sheet.
- IRON has $615.92M in cash and short term investments. This is sufficient to cover its annual cash burn of $166.03M.
Is it a good time to buy IRON stock, according to analysts?
Out of 8 sell side analysts who give ratings on IRON, the consensus analyst rating on IRON is a Strong Buy
Please keep in mind that analyst forecasts are not recommendations, nor are they investment advice.
Most Recent IRON Analyst Upgrades/Downgrades
Danielle Brill, a top 19% analyst from Truist Securities maintains IRON with a strong buy rating and raises their IRON price target from $86.00 to $114.00, on Nov 10, 2025.
Truist Securities's Danielle Brill raised their price target on Disc Medicine (NASDAQ: IRON) by 32.6% from $86 to $114 on 2025/11/10. The analyst maintained their Strong Buy rating on the stock.
Disc Medicine reported its Q3 2025 earnings.
Factors Brill cited for their revised model included:
- The quarter's results.
- The full U.S. bitopertin opportunity in EPP.
- An accelerated launch timeline following receipt of the FDA Commissioner's priority review vouchers.
Earnings Report
For Q3 2025, Disc Medicine reported:
- Loss per share of $1.77, compared to Q32 2024’s loss per share of $0.89.
Management did not provide EPS and revenue guidance in its press release.
President & CEO John Quisel, J.D., Ph.D. commented: “We are incredibly proud of the progress across our entire pipeline this quarter, most notably around our NDA submission for bitopertin in EPP at the end of 2025/09 and subsequent receipt of the CNPV.
“Achieving this milestone is a strong testament to our team’s commitment to execution and dedication to bringing a potential new treatment option to the EPP patient community.
“We continue to work with the Agency on their review of our application, and we are furthering our commercial infrastructure in preparation for a potential launch.
“Beyond bitopertin, our broader pipeline is progressing well, as we expect new data from the Phase 2 trial of DISC-0974 in MF anemia by the end of the year and data from studies of DISC-3405 in PV and SCD next year.
“With a strong balance sheet providing cash runway into 2029, we are well-positioned to prepare for the anticipated launch of bitopertin and ultimately advancing towards our goal of delivering new treatment options to patients suffering from hematological diseases.”
Sean Laaman, a top 25% analyst from Morgan Stanley maintains IRON with a strong buy rating and raises their IRON price target from $90.00 to $115.00, on Oct 30, 2025.
Martin Auster, a top 23% analyst from Raymond James maintains IRON with a strong buy rating and raises their IRON price target from $89.00 to $108.00, on Oct 17, 2025.
You can dig deeper into what analysts are saying on the Disc Medicine stock forecast page.
IRON Momentum
Who is buying/selling IRON?
Over the past year, executives and large shareholders at IRON have sold more shares than they have bought.
Jean M. Franchi, Chief Financial Officer of IRON, was the latest IRON insider to sell. They sold $220,838.97 worth of IRON shares on Feb 18, 2026.
Learn more about who owns IRON shares here.
Does IRON provide a stable income stream?
No, Disc Medicine doesn't provide an income stream by paying out dividends.
What others are saying about IRON
One of the reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other traders have to say.
Step 5: Make your IRON buy order
You have two primary order types:
- Market order: A market order is an order to buy or sell a stock at the best price on the market.
Market orders are generally fine. - Limit order: A limit order allows you to buy or sell a stock at a specific price (or better).
If you want to ensure you're buying or selling at an exact dollar amount limit, place a limit order.
Hit the Open Trade button and your broker will place your order.
If you require additional assistance buying stocks on eToro, watch the how to video below:
Step 6: Watch your IRON position
Now that you own some IRON shares, you'll want to keep up with your new investment.
Make a watchlist to track the most important metrics related to your IRON stock.
IRON Feed
How to Buy Stock in Disc Medicine
To summarize, here are the 6 steps to buy stock in Disc Medicine:
- Figure out where to buy Disc Medicine stock
- Open a brokerage account
- Deposit money your brokerage account
- Research Disc Medicine stock
- Make your IRON buy order
- Watch your IRON position
If you are looking for a place to buy stocks, eToro is our favorite option.
Get Started with eToro TodayIf you want to get updates on your new investment in Disc Medicine, create your watchlist below.
More Content You Might Like
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.